Novel roles of nitric oxide in hemorrhagic shock

Shock

Volumn 12, Issue 1, 1999, Pages 1-9

  Szabó, Csaba ^a,b   Billiar, Timothy R ^c,d  

^a INOTEK CORPORATION   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytokines; Endotoxin; Gene expression; Hemorrhage; Inducible nitric oxide synthase; Interleukin; Nitric oxide; Peroxynitrite; Poly (ADP ribose) synthetase; Sepsis

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2A PROTEIN, HUMAN;

ANIMAL; HEMORRHAGIC SHOCK; HUMAN; METABOLISM; MOUSE; REVIEW;

ANIMALS; HUMANS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SHOCK, HEMORRHAGIC;

EID: 0033163123     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199907000-00001     Document Type: Review

References (113)

1. Marletta MA: Nitric oxide synthase structure and mechanism. J Biol Chem 268:12231-4, 1993.
2. Stuehr DJ: Structure-function aspects in the nitric oxide synthases. Ann Rev Pharmacol Toxicol 37:339-59, 1997.
3. Geller DA, Billiar TR: Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 17:7-23, 1998
4. Ignarro LJ: Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485-90, 1991.
5. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-41, 1991.
6. Dusting GJ: Nitric oxide in cardiovascular disorders. J Vasc Res 32:143-61, 1995.
7. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-64, 1992.
8. Salvemini D, Masferrer JL. Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies. Methods Enzymol 269:12-25, 1996.
9. Khatsenko O, Gross SS, Rifkind AB, Vane JR: Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA 90:11147-51, 1993.
10. Felley-Bosco E, Ambs S, Lowenstein CJ, Keefer LK, Harris CC: Constitutive expression of inducible nitric oxide synthase in human bronchial epithelial cells induces c-fos and stimulates the cGMP pathway. Am J Respir Cell Mol Biol 11:159-64, 1994.
11. Peunova N, Enikolopov G: Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 364:450-3, 1993.
12. Sessa WC: The nitric oxide family of proteins. J Vasc Res 31:131-43, 1994.
13. Harbrecht BG, Wu B, Watkins SC, Marshall HP Jr, Peitzman AB, Billiar TR: Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 4:332-7, 1995.
14. Adachi T, Hori S, Miyazaki K, Nakagawa M, Inoue S, Ohnishi Y, Nakazawa H, Aikawa N, Ogawa S: Inhibition of nitric oxide synthesis aggravates myocardial ischemia in hemorrhagic shock in constant pressure model. Shock 9:204-209, 1998.
15. Todorovic Z, Prostran MS, Varagic V, Zunic G, Savic J, Vujnov S: The cardiovascular effects of the administration of L-NAME during the early posthemorrhagic period. Gen Pharmacol 30:763-9, 1998.
16. Harbrecht BG, Wu B, Watkins SC, Billiar TR, Peitzman AB: Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 8:415-21, 1997.
17. Szabó C, Faragó M, Horváth I, Lohinai Z, Kovách AGB: Hemorrhagic hypotension impairs endothelium-dependent relaxations in the renal artery of the cat. Circ Shock 36:238-41, 1992.
18. Wang P, Ba Z, Chaudry IH: Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am J Physiol 265:H973-9, 1993.
19. Szabó C, Thiemermann C: Role of nitric oxide in haemorrhagic, traumatic and anaphylactic shock and in thermal injury. Shock 2:145-55, 1994.
20. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182:1683-93, 1995.
21. Palmer LA, Johns RA: Hypoxia upregulates inducible (Type II) nitric oxide synthase in an HIF-1 dependent manner in rat pulmonary microvascular but not aortic smooth muscle cells. Chest 114:33S-4S, 1998.
22. Nathan Q, Xie Q: Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-8, 1994.
23. DeVera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, Billiar TR: Transcriptional regulation of human inducible nitric oxide synthase gene by cytokines: initial analysis of human NOS2 promoter. Proc Natl Acad Sci USA 93:1054-9, 1996.
24. Linn C, Morelli PJ, Edry I, Cottongim SE, Szabó C, Salzman AL: Promoter analysis of the human inducible nitric oxide synthase gene suggests both transcriptional and post-transcriptional regulation. Am J Physiol 272:G1499-508, 1997.
25. Gross SS, Levi R: Tetrahydrobiopterin synthesis: An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267:25722-9, 1992
26. Nussler AK, Billiar TR, Liu ZZ, Morris SM: Coinduction of nitric oxide synthase and arginosuccinate synthetase in a murine macrophage cell line. J Biol Chem 269:1257-61, 1994.
27. Palmer RMJ, Bridge L, Foxwell NA, Moncada: The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 105:11-2, 1992.
28. Szabó C: Alterations in the production of nitric oxide in various forms of circulatory shock. New Horizons 3:3-32, 1995.
29. Kim YM, Talanian RV, Billiar TR: Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272:31138-48, 1997.
30. Ou J, Carlos TM, Watkins SC, Saavedra JE, Keefer LK, Kim YM, Harbrecht BG, Billiar TR: Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. NO: Biol Chem 1:404-16, 1997.
31. Kim YM, de Vera ME, Watkins SC, Billiar TR: Nitric oxide protects cultured rat hepatocytes from TNFα-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402-11, 1997.
32. Tzeng E, Kim YM, Pitt BR, Lizonova A, Kovesdi I, Billiar TR: Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122:255-63, 1997.
33. Salzman AL: Nitric oxide in the gut. New Horiz 3:352-64, 1997.
34. Pfeilschifter J, Eberhardt W, Hummel R, Kunz D, Muhl H, Nitsch D, Pluss C, Walker G: Therapeutic strategies for the inhibition of inducible nitric oxide synthase: potential for a novel class of anti-inflammatory agents. Cell Biol Int 20:51-8, 1996.
35. Southan GJ, Szabó C: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51:383-94, 1996.
36. Clancy RM, Amin AR, Abramson SB: The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141-51, 1998.
37. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417-23, 1997.
38. Westenberger U, Thanner S, Ruf HH, Gersonde K, Sutter G, Trentz O: Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. Free Radical Res Comm 11:167-78, 1990.
39. Thiemermann C, Szabó C, Mitchell JA, Vane JR: Vascular hyporeactivity to vasoconstrictor agents and haemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90:267-71, 1993.
40. Kelly E, Shah NS, Morgan NN, Watkins SC, Peitzman AB, Billiar TR: Physiologic and molecular characterization of the role of nitric oxide in hemorrhagic shock. Shock 7:157-63, 1997.
41. Zhu XH, Zhu XL, Zellweger R, Ayala A, Chaudry IH: Inducible nitric oxide synthase mRNA expression in murine peritoneal macrophages, splenic macrophages and Kupffer cells following hemorrhage. Shock 3(Suppl):13, 1995.
42. G-methyl-L-arginine restores arterial pressure in hemorrhaged rats. Circ Shock 40:47-52, 1993
43. Yao YM, Bahrami S, Leichtfried G, Redl H, Schlag G: Significance of NO in hemorrhage-induced hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 270:H1616-23, 1996.
44. Lieberthal W, McGarry AE, Sheils J, Valeri CR: Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Am J Physiol 261:F868-72, 1991.
45. Zingarelli B, Squadrito F, Altavilla D, Calapai G, Campo GM, Calo M, Saitta A, Caputi AP: Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. J Cardiovasc Pharmacol 19:982-6, 1992.
46. Thiemermann C, Wu CC, Piper J, Chen SJ, Szabó C, Vane JR: Aminoguanidine attenuates the delayed circulatory failure in endotoxic and haemorrhagic shock in the anaesthetized rat. Can J Physiol Pharmacol (Suppl. 1)471, 1997.
47. G-nitro-L-arginine methyl ester on the survival rate in a rat model of hemorrhagic shock. Shock, 11:51-7, 1999.
48. Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C: Spontaneous rearrangement of aminoalkylguanidines into mercaptoalkylguanidines - a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J. Pharmacol 117:619-32, 1996.
49. Szabó C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R: Mercaptoethylguanidine and related guanidine nitric oxide synthase inhibitors react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 272:9030-6, 1997.
50. Zingarelli B, Ischiropoulos H, Salzman AL, Szabó C: Improved vascular contractility and cellular energetics in the delayed phase of hemorrhagic shock by mercaptoethylguanidine, a novel inhibitor of the inducible isoform of nitric oxide synthase. Eur J Pharmacol 338:55-65, 1997.
51. Szabó A, Hake P, Salzman AL, Szabó C: Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and a scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit Care Med, in press, 1999.
52. Thiemermann C: Nitric oxide and septic shock. Gen Pharmacol 29:159-66, 1997.
53. Shahidi H, Kilbourn RG: The role of nitric oxide in interleukin-2 therapy induced hypotension. Cancer Metastasis Rev 17:119-26, 1998.
54. Parratt JR: Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother 41 (Suppl A):31-9, 1998.
55. Szabó C: Role of nitric oxide in endotoxic shock: An overview of recent advances. Ann NY Acad Sci 851:422-5, 1998.
56. Tan LR, Waxman K, Clark L, Eloi L, Chhieng N, Miller B, Young A: Superoxide dismutase and allopurinol improve survival in an animal model of hemorrhagic shock. Am Surg 59:797-800, 1993.
57. Fleckenstein AE, Smith SL, Linseman KL, Beuving LJ, Hall ED: Comparison of the efficacy of mechanistically different antioxidants in the rat hemorrhagic shock model. Circ Shock 35:223-30, 1991.
58. Kapoor R, Prasad K: Role of oxyradicals in cardiovascular depression and cellular injury in haemorrhagic shock and reinfusion: effect of SOD and catalase. Circ Shock 43:79-94, 1994.
59. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-37, 1996.
60. Szabó C: The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock 6:79-88, 1996.
61. Angele MK, Smail N, Wang P, Cioffi WG, Bland KI, Chaudry IH: L-arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. Surgery 124:394-401, 1998.
62. Xia Y, Dawson VL, Dawson TM, Snyder S.H, Zweier JL: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93:6110-4, 1996.
63. Xia Y, Zweier JL: Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94:6954-8, 1997.
64. Nohl H: Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin 52:199-204, 1994.
65. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J, Lefer, AM: Peroxynitrite inhibits leukocyte-endothelial interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 99:684-91, 1997.
66. Moro MA, Darley-Usmar VM, Lizasoain I, Su Y, Knowles RG, Radomski MW, Moncada S: The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol 116:1999-2004, 1995.
67. Tarpey MM, Beckman JS, Ischiropoulos H, Gore JZ, Brock TA: Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis. FEBS Lett 364:314-8, 1995.
68. Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K: Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase: Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 270:17355-60, 1995.
69. Davidson CA, Kaminski PM, Wolin MS: NO elicits prolonged relaxation of bovine pulmonary arteries via endogenous peroxynitrite generation. Am J Physiol 273:L437-44, 1997.
70. Kooy N, Royall J, Ischiropoulos H, Beckman J: Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Rad Biol Med 16:149-55, 1994.
71. Szabó C, Salzman AL, Ischiropoulos H: Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 363:235-8, 1995.
72. Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 121:1065-74, 1997.
73. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS: Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298:431-7, 1992.
74. Eiserich JP, Cross CE, Jones AD, Halliwell B, Van der Vliet A: Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271:19199-208, 1996.
75. Eiserich J P, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, Van der Vliet A: Formation of nitric oxide derivatives catalysed by myeloperoxidase in neutrophils. Nature 391:393-7, 1997.
76. Halliwell B: What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411:157-60, 1997.
77. Szabó C, Salzman AL: Endogenous peroxynitrite is involved in the inhibition of cellular respiration in immuno-stimulated J774.2 macrophages. Biochem Biophys Res Comm 209:739-43, 1995.
78. Szabó C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the nitric oxide- and peroxynitrite-induced vascular failure. Circ Res 78:1051-63, 1996.
79. Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H: Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 94:2528-33, 1997.
80. Ames BN, Cathcart R, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858-62, 1981.
81. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86:6377-81, 1989.
82. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269:26066-75, 1994.
83. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB: Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 271:40-7, 1996.
84. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ: Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 93:15069-74, 1996.
85. Szabó C, Ohshima H: DNA injury induced by peroxynitrite. Nitric Oxide Biol Chem 1:323-85, 1997.
86. Szabó C: Role of poly (ADP-ribose) synthetase in inflammation. Eur J Pharmacol 350:1-19, 1998.
87. Szabó C, Dawson VL: Role of poly (ADP-ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol Sci 19:287-98, 1998.
88. Virág L, Scott GS, Salzman AL, Szabó C: Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly-(ADP-ribose) synthetase (PARS) activation. Immunology 94:345-55, 1998.
89. Virág L, Manner DJ, Szabó C: The crucial role of apopain/caspase-3 in the peroxynitrite-induced apoptotic DNA fragmentation. Free Rad Biol Med 25:1075-82 1998.
90. Virág L, Salzman AL, Szabó C: Poly (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161:3753-9, 1998.
91. O'Connor M, Salzman AL, Szabó C: Role of peroxynitrite in the protein oxidation and apoptotic DNA fragmentation in immunostimulated vascular smooth muscle cells. Shock 8:439-43, 1997.
92. Leist M, Single B, Kunstle G, Volbracht C, Hentze H, Nicotera P: Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Comm 233:518-22, 1997.
93. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL: Endothelial dysfunction in endotoxic shock: importance of the activation of poly (ADP ribose) synthetase (PARS) by peroxynitrite. J Clin Invest 100:723-35, 1997.
94. Szabó C: Potential role of the peroxynitrite-poly (ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock 9:341-4, 1998.
95. Szabó A, Hake P, Salzman AL, Szabó C: Inhibition of poly (ADP-ribose) synthetase exerts protective effects in a porcine model of hemorrhagic shock. Shock 10:347-53, 1998.
96. Lin KT, Xue JY, Lin MC, Spokas EG, Sun FF, Wong PY: Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease. Am J Physiol 274:C855-60, 1998.
97. Yaoita H, Ogawa K, Maehara K, Maruyama Y: Attenuation of ischemia/ reperfusion injury in rats by a caspase inhibitor. Circulation 97:276-81, 1998.
98. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, Hyman BT, Moskowitz MA: Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 18:238-47, 1998.
99. Hierholzer C, Kelly E, Tsukada K, Loeffert E, Watkins S, Billiar TR, Tweardy DJ: Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol 273:L1058-64, 1997.
100. Omert LA, Billiar TR: Hemorrhagic shock: from physiology to molecular biology. In: Proceedings of the Eleventh International Postgraduate Course on Critical Care Medicine, Trieste Italy, Vol. 27: Cardiovascular Support by Hemodynamic Subsets. Springer Verlag, Heidelberg, 1997, pp. 207-17.
101. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, Tweardy DJ: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187:917-28, 1998.
102. Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, Quilliam LA: A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem 272:4323-6, 1997.
103. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L: Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 158:2940-6, 1997.
104. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Di Battista JA, Martel-Pelletier J: Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41:1275-86, 1998.
105. Brahn E, Banquerigo ML, Firestein GS, Boyle DL, Salzman AL, Szabó C: Collagen-induced arthritis: reversal by mercaptoethylguanidine, a novel anti-inflammatory agent with a combined mechanism of action. J Rheumat 25:1785-93, 1998.
106. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C: Type 1 interferon (IF-Nalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77-87, 1998.
107. Ajuebor MN, Virág L, Flower RJ, Perretti M, Szabó C: Role of inducible nitric oxide synthase in the regulation of neutrophil migration in symosan-induced inflammation: relationship to IL-10 and chemokine production. Immunology 95:625-30 1998.
108. Zielasek J, Jung S, Gold R, Liew FY, Toyka KV, Hartung HP: Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J Neuroimmunol 58:81-8, 1995.
109. Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L: Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 58:2940-6, 1997.
110. Okuda Y, Sakoda S, Fujimura H, Yanagihara T: Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J Neuroimmunol 81:201-10, 1998.
111. Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS: Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 160:2940-6, 1998.
112. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261:1445-8, 1993.
113. Karupiah G, Chen JH, Mahalingam S, Nathan CF, MacMicking JD: Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 188:1541-6, 1998.